Alentis Therapeutics
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
73 employees · est. 2019 · Allschwil, Switzerland
Pliant Therapeutics
We are transforming the lives of patients by developing best-in-class treatments for fibrotic diseases.
183 employees · est. 2015 · South San Francisco, United...
Pliant Therapeutics is the older company (2019 vs 2015).
Side-by-Side Comparison
| Metric | Alentis Therapeutics | Pliant Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2015 older |
| Headquarters | ||
| Headquarters | Allschwil, Switzerland | South San Francisco, United States |
| Employees | ||
| Employees | 73 | 183 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series D | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $364.50M | $694.95M |
| Funding Rounds | ||
| Funding Rounds | 4 | 5 |
| Services | ||
| Services | Development of anti-Claudin-1 ADCs, Clinical trials for monoclonal antibodies, Fibrosis study results publication, Leadership in therapeutic development | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Patients with organ fibrosis, Healthcare professionals, Biotech investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Claudin-1, Tumor Treatment, Organ Fibrosis, Antibody-drug Conjugates, Oncology, Liver Fibrosis, Kidney Fibrosis, Lung Fibrosis, Cancer Therapy, Clinical-stage Biotechnology, Multi-organ Fibrosis, Drug Discovery, Drug Development, Rare Diseases, Nephrology | Biopharmaceutical, Fibrosis, Integrin Biology, TGF-β Modulation, Drug Development, Clinical Trials, Orphan Drug Designation, Nonalcoholic Steatohepatitis (NASH), Muscular Dystrophies, Oncology, Idiopathic Pulmonary Fibrosis (IPF), Primary Sclerosing Cholangitis (PSC), Therapeutic Treatments, South San Francisco, California, Diversity And Inclusion Initiatives |
| Website | ||
| Website | alentis.ch | pliantrx.com |
About Alentis Therapeutics
Alentis Therapeutics, founded in 2019, is a pioneering clinical-stage biotechnology company with a focus on developing breakthrough treatments for Claudin1-positive tumors and organ fibrosis. The company is based in the pharma-biotech hub of Basel, Switzerland. The company specializes in first-in-c...
About Pliant Therapeutics
Pliant Therapeutics is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutics for the treatment of fibrotic diseases. With a commitment to driving innovative science to address areas of unmet medical need, Pliant aims to transform the lives of pa...
We will tell you when either one moves
BounceWatch watches Alentis Therapeutics and Pliant Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Alentis Therapeutics and Pliant Therapeutics — by email.
Frequently Asked Questions
Compare Alentis Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Alentis Therapeutics on 28 Jan 2026, and Pliant Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
